Correlation Between Bionoid Pharma and Crescita Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Crescita Therapeutics, you can compare the effects of market volatilities on Bionoid Pharma and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Crescita Therapeutics.

Diversification Opportunities for Bionoid Pharma and Crescita Therapeutics

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Bionoid and Crescita is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Crescita Therapeutics go up and down completely randomly.

Pair Corralation between Bionoid Pharma and Crescita Therapeutics

Given the investment horizon of 90 days Bionoid Pharma is expected to under-perform the Crescita Therapeutics. In addition to that, Bionoid Pharma is 1.54 times more volatile than Crescita Therapeutics. It trades about -0.2 of its total potential returns per unit of risk. Crescita Therapeutics is currently generating about -0.22 per unit of volatility. If you would invest  45.00  in Crescita Therapeutics on October 21, 2024 and sell it today you would lose (6.00) from holding Crescita Therapeutics or give up 13.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Bionoid Pharma  vs.  Crescita Therapeutics

 Performance 
       Timeline  
Bionoid Pharma 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.
Crescita Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Crescita Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Bionoid Pharma and Crescita Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionoid Pharma and Crescita Therapeutics

The main advantage of trading using opposite Bionoid Pharma and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.
The idea behind Bionoid Pharma and Crescita Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Money Managers
Screen money managers from public funds and ETFs managed around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm